{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:51:18Z","timestamp":1775800278761,"version":"3.50.1"},"reference-count":88,"publisher":"Bentham Science Publishers Ltd.","issue":"22","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2019,9,20]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Glaucoma is the second leading cause of blindness in the world, affecting more\nthan 60 million people globally. In order to reduce the progression of the disease, both\nmedical and surgical treatments are used. Frequent side effects of both treatments include a\nrange of modifications of the ocular surface grouped as the Ocular Surface Disease (OSD),\nwhich include Dry Eye Disease (DED). DED and other OSD negatively impact on the success\nof anti-glaucoma treatments and reduce the adherence to medical therapies. Tear film\nosmolarity (TFO) is a relatively novel test which has become a hallmark of DED. The aim\nof this paper was to review the association between OSD, DED and glaucoma in view of\npublished TFO data, and to discuss future fields of research and treatments on the topic of\nglaucoma iatrogenic damage.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867326666190725160621","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T01:50:46Z","timestamp":1568166646000},"page":"4241-4252","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Tear Film Osmolarity, Ocular Surface Disease and Glaucoma: A Review"],"prefix":"10.2174","volume":"26","author":[{"given":"Paolo","family":"Fogagnolo","sequence":"first","affiliation":[{"name":"Eye Clinic, San Paolo Hospital, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Torregrossa","sequence":"additional","affiliation":[{"name":"Eye Clinic, San Paolo Hospital, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Tranchina","sequence":"additional","affiliation":[{"name":"Eye Clinic, San Paolo Hospital, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ferreras","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Miguel Servet University Hospital, University of Zaragoza, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"De Cill\u00e1","sequence":"additional","affiliation":[{"name":"Unit of Ophthalmology, Ospedale Maggiore della Carita, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Labb\u00e9","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology III, Quinze-Vingts National Ophthalmology Hospital, Vision Institute, Versailles Saint-Quentin en Yvelines University, 75012 Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Figus","sequence":"additional","affiliation":[{"name":"Ophthalmology, Department of Neurosciences, University of Pisa, Pisa, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Ottobelli","sequence":"additional","affiliation":[{"name":"Eye Clinic, San Paolo Hospital, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Rossetti","sequence":"additional","affiliation":[{"name":"Eye Clinic, San Paolo Hospital, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"Quigley H.A.","year":"2006","unstructured":"Quigley H.A.; Broman A.T.; The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006,90(3),262-267","journal-title":"Br J Ophthalmol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1517\/13543784.2011.579901","volume":"20","author":"Fogagnolo P.","year":"2011","unstructured":"Fogagnolo P.; Rossetti L.; Medical treatment of glaucoma: present and future. Expert Opin Investig Drugs 2011,20(7),947-959","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00417-008-0881-9","volume":"246","author":"Erb C.","year":"2008","unstructured":"Erb C.; Gast U.; Schremmer D.; German register for glaucoma patients with dry eye. I. Basic outcome with respect to dry eye. Graefe\u2019s archive for clinical and experimental ophthalmology =. Albrecht Von Graefes Arch Klin Exp Ophthalmol 2008,246(11),1593-1601","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/IJG.0b013e31815c5f4f","volume":"17","author":"Leung E.W.","year":"2008","unstructured":"Leung E.W.; Medeiros F.A.; Weinreb R.N.; Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008,17(5),350-355","journal-title":"J Glaucoma"},{"key":"ref=5","first-page":"441","volume":"6","author":"Garcia-Feijoo J.","year":"2012","unstructured":"Garcia-Feijoo J.; Sampaolesi J.R.; A multicenter evaluation of ocular surface disease prevalence in patients with glaucoma. Clin Ophthalmol 2012,6,441-446","journal-title":"Clin Ophthalmol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/ICO.0b013e3181ae8402","volume":"28","author":"Baudouin C.","year":"2009","unstructured":"Baudouin C.; The ocular surface in glaucoma. Cornea 2009,28(11),S14-S19","journal-title":"Cornea"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jtos.2017.05.004","volume":"15","author":"Gomes J.A.P.","year":"2017","unstructured":"Gomes J.A.P.; Azar D.T.; Baudouin C.; Efron N.; Hirayama M.; Horwath-Winter J.; Kim T.; Mehta J.S.; Messmer E.M.; Pepose J.S.; Sangwan V.S.; Weiner A.L.; Wilson S.E.; Wolffsohn J.S.; TFOS DEWS II iatrogenic report. Ocul Surf 2017,15(3),511-538","journal-title":"Ocul Surf"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/ICO.0000000000000838","volume":"35","author":"Uzunosmanoglu E.","year":"2016","unstructured":"Uzunosmanoglu E.; Mocan M.C.; Kocabeyoglu S.; Karakaya J.; Irkec M.; Meibomian gland dysfunction in patients receiving long-term glaucoma medications. Cornea 2016,35(8),1112-1116","journal-title":"Cornea"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1016\/j.ophtha.2004.06.023","volume":"111","author":"Baudouin C.","year":"2004","unstructured":"Baudouin C.; Hamard P.; Liang H.; Creuzot-Garcher C.; Bensoussan L.; Brignole F.; Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology 2004,111(12),2186-2192","journal-title":"Ophthalmology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/bjo.86.4.418","volume":"86","author":"Pisella P.J.","year":"2002","unstructured":"Pisella P.J.; Pouliquen P.; Baudouin C.; Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002,86(4),418-423","journal-title":"Br J Ophthalmol"},{"key":"ref=11","unstructured":"Dry Eye Workshop 2017 (TFOS DEWS II)"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"7260","DOI":"10.1167\/iovs.15-17772","volume":"56","author":"Downie L.E.","year":"2015","unstructured":"Downie L.E.; Automated tear film surface quality breakup time as a novel clinical marker for tear hyperosmolarity in dry eye disease. Invest Ophthalmol Vis Sci 2015,56(12),7260-7268","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1136\/bjo.76.3.157","volume":"76","author":"Rieger G.","year":"1992","unstructured":"Rieger G.; The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol 1992,76(3),157-158","journal-title":"Br J Ophthalmol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/0002-9394(88)90062-1","volume":"105","author":"Lemp M.A.","year":"1988","unstructured":"Lemp M.A.; Zimmerman L.E.; Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Toxic endothelial degeneration in ocular surface disease treated with topical medications containing benzalkonium chloride. Am J Ophthalmol 1988,105(6),670-673","journal-title":"Am J Ophthalmol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1167\/iovs.07-1142","volume":"49","author":"Lee J.H.","year":"2008","unstructured":"Lee J.H.; Kim M.; Im, Y.S.; Choi, W.; Byeon, S.H.; Lee, H.K. NFAT5 induction and its role in hyperosmolar stressed human limbal epithelial cells. Invest Ophthalmol Vis Sci 2008,49(5),1827-1835","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/ICO.0b013e31817f4075","volume":"27","author":"Pflugfelder S.C.","year":"2008","unstructured":"Pflugfelder S.C.; de Paiva C.S.; Li D.Q.; Stern M.E.; Epithelial-immune cell interaction in dry eye. Cornea 2008,27(Suppl. 1),S9-S11","journal-title":"Cornea"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1167\/iovs.05-1382","volume":"47","author":"Corrales R.M.","year":"2006","unstructured":"Corrales R.M.; Stern M.E.; De Paiva C.S.; Welch J.; Li D.Q.; Pflugfelder S.C.; Desiccating stress stimulates expression of matrix metalloproteinases by the corneal epithelium. Invest Ophthalmol Vis Sci 2006,47(8),3293-3302","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1167\/iovs.03-1145","volume":"45","author":"Luo L.","year":"2004","unstructured":"Luo L.; Li D.Q.; Doshi A.; Farley W.; Corrales R.M.; Pflugfelder S.C.; Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004,45(12),4293-4301","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/01.ICL.0000162759.79740.46","volume":"31","author":"Luo L.","year":"2005","unstructured":"Luo L.; Li D.Q.; Corrales R.M.; Pflugfelder S.C.; Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens 2005,31(5),186-193","journal-title":"Eye Contact Lens"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1167\/iovs.02-0581","volume":"44","author":"Yeh S.","year":"2003","unstructured":"Yeh S.; Song X.J.; Farley W.; Li D.Q.; Stern M.E.; Pflugfelder S.C.; Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003,44(1),124-129","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0161-6420(89)32753-9","volume":"96","author":"Gilbard J.P.","year":"1989","unstructured":"Gilbard J.P.; Rossi S.R.; Heyda K.G.; Tear film and ocular surface changes after closure of the meibomian gland orifices in the rabbit. Ophthalmology 1989,96(8),1180-1186","journal-title":"Ophthalmology"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","volume":"11","author":"Baudouin C.","year":"2013","unstructured":"Baudouin C.; Aragona P.; Messmer E.M.; Tomlinson A.; Calonge M.; Boboridis K.G.; Akova Y.A.; Geerling G.; Labetoulle M.; Rolando M.; Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013,11(4),246-258","journal-title":"Ocul Surf"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","volume":"15","author":"Belmonte C.","year":"2017","unstructured":"Belmonte C.; Nichols J.J.; Cox S.M.; Brock J.A.; Begley C.G.; Bereiter D.A.; Dartt D.A.; Galor A.; Hamrah P.; Ivanusic J.J.; Jacobs D.S.; McNamara N.A.; Rosenblatt M.I.; Stapleton F.; Wolffsohn J.S.; TFOS DEWS II pain and sensation report. Ocul Surf 2017,15(3),404-437","journal-title":"Ocul Surf"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3109\/02713683.2010.484557","volume":"35","author":"Versura P.","year":"2010","unstructured":"Versura P.; Profazio V.; Campos E.C.; Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res 2010,35(7),553-564","journal-title":"Curr Eye Res"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1167\/iovs.10-5390","volume":"51","author":"Sullivan B.D.","year":"2010","unstructured":"Sullivan B.D.; Whitmer D.; Nichols K.K.; Tomlinson A.; Foulks G.N.; Geerling G.; Pepose J.S.; Kosheleff V.; Porreco A.; Lemp M.A.; An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci 2010,51(12),6125-6130","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1167\/iovs.05-1504","volume":"47","author":"Tomlinson A.","year":"2006","unstructured":"Tomlinson A.; Khanal S.; Ramaesh K.; Diaper C.; McFadyen A.; Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006,47(10),4309-4315","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"792-798 e1","DOI":"10.1016\/j.ajo.2010.10.032","volume":"151","author":"Lemp M. A.","year":"2011","unstructured":"Lemp M. A.; Bron A. J.; Baudouin C.; Benitez Del Castillo J. M.; Geffen D.; Tauber J.; Foulks G. N.; Pepose J. S.; Sullivan B. D.; Tear osmolarity in the diagnosis and\nmanagement of dry eye disease. American journal of ophthalmology 2011,151(5),792-798 e1","journal-title":"American journal of ophthalmology"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1001\/jamaophthalmol.2015.3854","volume":"133","author":"Sullivan B.D.","year":"2015","unstructured":"Sullivan B.D.; Pepose J.S.; Foulks G.N.; Progressively increased variation in tear osmolarity mirrors dry eye severity. JAMA Ophthalmol 2015,133(12),1481-1482","journal-title":"JAMA Ophthalmol"},{"key":"ref=29","unstructured":"Available at(accessed on 3rd November\n2017)."},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/eye.2013.144","volume":"27","author":"Lee S.Y.","year":"2013","unstructured":"Lee S.Y.; Wong T.T.; Chua J.; Boo C.; Soh Y.F.; Tong L.; Effect of chronic anti-glaucoma medications and trabeculectomy on tear osmolarity. Eye (Lond) 2013,27(10),1142-1150","journal-title":"Eye (Lond)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1097\/ICO.0b013e31823f8cb6","volume":"31","author":"Labb\u00e9 A.","year":"2012","unstructured":"Labb\u00e9 A.; Terry O.; Brasnu E.; Van Went C.; Baudouin C.; Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Cornea 2012,31(9),994-999","journal-title":"Cornea"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/jop.2014.0124","volume":"31","author":"Halkiadakis I.","year":"2015","unstructured":"Halkiadakis I.; Kontadakis G.A.; Tsiakou D.; Patsea E.; Mitropoulos P.; Kandarakis A.S.; Effect of glaucoma medication in tear film osmolarity of patients without symptoms of ocular discomfort. J Ocul Pharmacol Ther 2015,31(6),330-334","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/jop.2013.0174","volume":"30","author":"Rasmussen C.A.","year":"2014","unstructured":"Rasmussen C.A.; Kaufman P.L.; Kiland J.A.; Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther 2014,30(2-3),163-169","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=34","first-page":"851","volume":"18","author":"Clouzeau C.","year":"2012","unstructured":"Clouzeau C.; Godefroy D.; Riancho L.; Rost\u00e8ne W.; Baudouin C.; Brignole-Baudouin F.; Hyperosmolarity potentiates toxic effects of benzalkonium chloride on conjunctival epithelial cells in vitro. Mol Vis 2012,18,851-863","journal-title":"Mol Vis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/jcp.22389","volume":"226","author":"Png E.","year":"2011","unstructured":"Png E.; Samivelu G.K.; Yeo S.H.; Chew J.; Chaurasia S.S.; Tong L.; Hyperosmolarity-mediated mitochondrial dysfunction requires Transglutaminase-2 in human corneal epithelial cells. J Cell Physiol 2011,226(3),693-699","journal-title":"J Cell Physiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/ICO.0b013e318030d259","volume":"26","author":"Luo L.","year":"2007","unstructured":"Luo L.; Li D.Q.; Pflugfelder S.C.; Hyperosmolarity-induced apoptosis in human corneal epithelial cells is mediated by cytochrome c and MAPK pathways. Cornea 2007,26(4),452-460","journal-title":"Cornea"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1167\/iovs.07-0720","volume":"49","author":"Xiong C.","year":"2008","unstructured":"Xiong C.; Chen D.; Liu J.; Liu B.; Li N.; Zhou Y.; Liang X.; Ma P.; Ye C.; Ge J.; Wang Z.; A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride. Invest Ophthalmol Vis Sci 2008,49(5),1850-1856","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=38","first-page":"257","volume":"17","author":"Lin Z.","year":"2011","unstructured":"Lin Z.; Liu X.; Zhou T.; Wang Y.; Bai L.; He H.; Liu Z.; A mouse dry eye model induced by topical administration of benzalkonium chloride. Mol Vis 2011,17,257-264","journal-title":"Mol Vis"},{"key":"ref=39","first-page":"642","volume":"42","author":"Debbasch C.","year":"2001","unstructured":"Debbasch C.; Brignole F.; Pisella P.J.; Warnet J.M.; Rat P.; Baudouin C.; Quaternary ammoniums and other preservatives\u2019 contribution in oxidative stress and apoptosis on Chang conjunctival cells. Invest Ophthalmol Vis Sci 2001,42(3),642-652","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1167\/iovs.05-0776","volume":"46","author":"Guenoun J.M.","year":"2005","unstructured":"Guenoun J.M.; Baudouin C.; Rat P.; Pauly A.; Warnet J.M.; Brignole-Baudouin F.; \n                        In vitro comparison of cytoprotective and antioxidative effects of latanoprost, travoprost, and bimatoprost on conjunctiva-derived epithelial cells. Invest Ophthalmol Vis Sci 2005,46(12),4594-4599","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1167\/iovs.08-2992","volume":"50","author":"Pauly A.","year":"2009","unstructured":"Pauly A.; Meloni M.; Brignole-Baudouin F.; Warnet J.M.; Baudouin C.; Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage. Invest Ophthalmol Vis Sci 2009,50(4),1644-1652","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1136\/bjo.2008.138768","volume":"92","author":"Liang H.","year":"2008","unstructured":"Liang H.; Baudouin C.; Pauly A.; Brignole-Baudouin F.; Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride. Br J Ophthalmol 2008,92(9),1275-1282","journal-title":"Br J Ophthalmol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/00055735-199604000-00014","volume":"7","author":"Baudouin C.","year":"1996","unstructured":"Baudouin C.; Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol 1996,7(2),80-86","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=44","first-page":"170","volume":"200","author":"Rolando M.","year":"1990","unstructured":"Rolando M.; Terragna F.; Giordano G.; Calabria G.; Conjunctival surface damage distribution in keratoconjunctivitis sicca. An impression cytology study. Ophthalmologica. Journal international d\u2019ophtalmologie. International journal of ophthalmology. Z Augenheilkd 1990,200(4),170-176","journal-title":"Z Augenheilkd"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s12325-008-0078-y","volume":"25","author":"Kahook M.Y.","year":"2008","unstructured":"Kahook M.Y.; Noecker R.; Quantitative analysis of conjunctival goblet cells after chronic application of topical drops. Adv Ther 2008,25(8),743-751","journal-title":"Adv Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"6499","DOI":"10.1167\/iovs.14-14548","volume":"55","author":"Barabino S.","year":"2014","unstructured":"Barabino S.; Antonelli S.; Cimbolini N.; Mauro V.; Bouzin M.; The effect of preservatives and antiglaucoma treatments on the ocular surface of mice with dry eye. Invest Ophthalmol Vis Sci 2014,55(10),6499-6504","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","volume":"115","author":"Baudouin C.","year":"2008","unstructured":"Baudouin C.; Liang H.; Hamard P.; Riancho L.; Creuzot-Garcher C.; Warnet J.M.; Brignole-Baudouin F.; The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008,115(1),109-115","journal-title":"Ophthalmology"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1177\/112067210801800314","volume":"18","author":"Ciancaglini M.","year":"2008","unstructured":"Ciancaglini M.; Carpineto P.; Agnifili L.; Nubile M.; Fasanella V.; Lanzini M.; Calienno R.; Mastropasqua L.; An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes. Eur J Ophthalmol 2008,18(3),400-407","journal-title":"Eur J Ophthalmol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1111\/aos.12261","volume":"92","author":"Frezzotti P.","year":"2014","unstructured":"Frezzotti P.; Fogagnolo P.; Haka G.; Motolese I.; Iester M.; Bagaglia S.A.; Mittica P.; Menicacci C.; Rossetti L.; Motolese E.; \n                        In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. Acta Ophthalmol 2014,92(2),e133-e140","journal-title":"Acta Ophthalmol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2147\/OPTH.S22874","volume":"5","author":"Ranno S.","year":"2011","unstructured":"Ranno S.; Fogagnolo P.; Rossetti L.; Orzalesi N.; Nucci P.; Changes in corneal parameters at confocal microscopy in treated glaucoma patients. Clin Ophthalmol 2011,5,1037-1042","journal-title":"Clin Ophthalmol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1089\/jop.2013.0216","volume":"30","author":"Iester M.","year":"2014","unstructured":"Iester M.; Telani S.; Frezzotti P.; Motolese I.; Figus M.; Fogagnolo P.; Perdicchi A.; Ocular surface changes in glaucomatous patients treated with and without preservatives beta-blockers. J Ocul Pharmacol Ther Beta-blocker study group2014,30(6),476-481","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref=52","first-page":"89","volume":"200","author":"Hoh H.","year":"1990","unstructured":"Hoh H.; [Preservative-free timolol eye drops--surface-anesthetic effect and local compatibility Ophthalmologica. Journal international d\u2019ophtalmologie. International journal of ophthalmology. Z Augenheilkd 1990,200(2),89-97","journal-title":"Z Augenheilkd"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2147\/OPTH.S14113","volume":"4","author":"Katz G.","year":"2010","unstructured":"Katz G.; Springs C.L.; Craven E.R.; Montecchi-Palmer M.; Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost. Clin Ophthalmol 2010,4,1253-1261","journal-title":"Clin Ophthalmol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/OPTH.S28104","volume":"6","author":"Janulevi\u010dien\u0117 I.","year":"2012","unstructured":"Janulevi\u010dien\u0117 I.; Derka\u010d I.; Grybauskiene L.; Paulauskait\u0117 R.; Gromnickaite R.; Kuzmien\u0117 L.; Effects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma. Clin Ophthalmol 2012,6,103-109","journal-title":"Clin Ophthalmol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/BF00182000","volume":"232","author":"Mietz H.","year":"1994","unstructured":"Mietz H.; Niesen U.; Krieglstein G.K.; The effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctiva. Graefe\u2019s archive for clinical and experimental ophthalmology =. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1994,232(9),561-565","journal-title":"Albrecht Von Graefes Arch Klin Exp Ophthalmol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/eye.1988.80","volume":"2","author":"Coleiro J.A.","year":"1988","unstructured":"Coleiro J.A.; Sigurdsson H.; Lockyer J.A.; Follicular conjunctivitis on Dipivefrin therapy for glaucoma. Eye (Lond) 1988,2(Pt 4),440-442","journal-title":"Eye (Lond)"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S0161-6420(85)34048-4","volume":"92","author":"Liesegang T.J.","year":"1985","unstructured":"Liesegang T.J.; Bulbar conjunctival follicles associated with dipivefrin therapy. Ophthalmology 1985,92(2),228-233","journal-title":"Ophthalmology"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1097\/01.ico.0000240084.27663.fd","volume":"25","author":"Fraunfelder F.W.","year":"2006","unstructured":"Fraunfelder F.W.; Corneal toxicity from topical ocular and systemic medications. Cornea 2006,25(10),1133-1138","journal-title":"Cornea"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1001\/archopht.1992.01080160106043","volume":"110","author":"Berdy G.J.","year":"1992","unstructured":"Berdy G.J.; Abelson M.B.; Smith L.M.; George M.A.; Preservative-free artificial tear preparations. Assessment of corneal epithelial toxic effects. Arch Ophthalmol 1992,110(4),528-532","journal-title":"Arch Ophthalmol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/02713689808951223","volume":"17","author":"Becquet F.","year":"1998","unstructured":"Becquet F.; Goldschild M.; Moldovan M.S.; Ettaiche M.; Gastaud P.; Baudouin C.; Histopathological effects of topical ophthalmic preservatives on rat corneoconjunctival surface. Curr Eye Res 1998,17(4),419-425","journal-title":"Curr Eye Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0161-6420(89)32888-0","volume":"96","author":"Sherwood M.B.","year":"1989","unstructured":"Sherwood M.B.; Grierson I.; Millar L.; Hitchings R.A.; Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon\u2019s capsule in glaucomatous patients. Ophthalmology 1989,96(3),327-335","journal-title":"Ophthalmology"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/j.1440-0960.2004.00074.x","volume":"45","author":"Mullins R.J.","year":"2004","unstructured":"Mullins R.J.; Lones R.; Dutta B.; Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops. Australas J Dermatol 2004,45(2),151-152","journal-title":"Australas J Dermatol"},{"key":"ref=63","first-page":"217-9","volume":"12","author":"Holdiness M. R.","year":"2001","unstructured":"Holdiness M. R.; Contact dermatitis to topical drugs for\nglaucoma. American journal of contact dermatitis: official\njournal of the American Contact Dermatitis Society 2001,12(4),217-9","journal-title":"American journal of contact dermatitis: official\njournal of the American Contact Dermatitis Society"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1023\/A:1005892426045","volume":"21","author":"Tura\u00e7li E.","year":"1997","unstructured":"Tura\u00e7li E.; Budak K.; Kaur A.; Mizrak B.; Ekinci C.; The effects of long-term topical glaucoma medication on conjunctival impression cytology. Int Ophthalmol 1997,21(1),27-33","journal-title":"Int Ophthalmol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1167\/iovs.03-1067","volume":"45","author":"Pisella P.J.","year":"2004","unstructured":"Pisella P.J.; Debbasch C.; Hamard P.; Creuzot-Garcher C.; Rat P.; Brignole F.; Baudouin C.; Conjunctival proinflammatory and proapoptotic effects of latanoprost and preserved and unpreserved timolol: an ex vivo and in vitro study. Invest Ophthalmol Vis Sci 2004,45(5),1360-1368","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=66","first-page":"679","volume":"42","author":"Mietz H.","year":"2001","unstructured":"Mietz H.; Schl\u00f6tzer-Schrehardt U.; Strassfeld C.; Krieglstein G.K.; Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci 2001,42(3),679-687","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1167\/iovs.07-0266","volume":"48","author":"Baudouin C.","year":"2007","unstructured":"Baudouin C.; Riancho L.; Warnet J.M.; Brignole F.; \n                        In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost. Invest Ophthalmol Vis Sci 2007,48(9),4123-4128","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/S0002-9394(00)00478-5","volume":"130","author":"Taguri A.H.","year":"2000","unstructured":"Taguri A.H.; Khan M.A.; Sanders R.; Marginal keratitis: an uncommon form of topical dorzolamide allergy. Am J Ophthalmol 2000,130(1),120-122","journal-title":"Am J Ophthalmol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12325-015-0205-5","volume":"32","author":"Fogagnolo P.","year":"2015","unstructured":"Fogagnolo P.; Dipinto A.; Vanzulli E.; Maggiolo E.; De Cilla\u2019 S.; Autelitano A.; Rossetti L.; A 1-year randomized study of the clinical and confocal effects of tafluprost and latanoprost in newly diagnosed glaucoma patients. Adv Ther 2015,32(4),356-369","journal-title":"Adv Ther"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000334791","volume":"50","author":"Baudouin C.","year":"2012","unstructured":"Baudouin C.; Ocular surface and external filtration surgery: mutual relationships. Dev Ophthalmol 2012,50,64-78","journal-title":"Dev Ophthalmol"},{"key":"ref=71","first-page":"19","author":"Coppens G.","year":"2010","unstructured":"Coppens G.; Maudgal P.; Corneal complications of intraoperative Mitomycin C in glaucoma surgery. Bull Soc Belge Ophtalmol 2010(314),19-23","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/ICU.0b013e328325a54b","volume":"20","author":"Hau S.","year":"2009","unstructured":"Hau S.; Barton K.; Corneal complications of glaucoma surgery. Curr Opin Ophthalmol 2009,20(2),131-136","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ajo.2006.01.018","volume":"141","author":"Sauder G.","year":"2006","unstructured":"Sauder G.; Jonas J.B.; Limbal stem cell deficiency after subconjunctival mitomycin C injection for trabeculectomy. Am J Ophthalmol 2006,141(6),1129-1130","journal-title":"Am J Ophthalmol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0002-9394(03)00085-0","volume":"136","author":"Wilson S.E.","year":"2003","unstructured":"Wilson S.E.; Netto M.; Ambr\u00f3sio R.; Corneal cells: chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol 2003,136(3),530-536","journal-title":"Am J Ophthalmol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1136\/bjo.84.11.1250","volume":"84","author":"Shimazaki J.","year":"2000","unstructured":"Shimazaki J.; Hanada K.; Yagi Y.; Yamagami J.; Ishioka M.; Shimmura S.; Tsubota K.; Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostone. Br J Ophthalmol 2000,84(11),1250-1254","journal-title":"Br J Ophthalmol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.exer.2006.03.015","volume":"83","author":"Dupps W.J.","year":"2006","unstructured":"Dupps W.J.; Wilson S.E.; Biomechanics and wound healing in the cornea. Exp Eye Res 2006,83(4),709-720","journal-title":"Exp Eye Res"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/archopht.1983.01040010385006","volume":"101","author":"Soong H.K.","year":"1983","unstructured":"Soong H.K.; Quigley H.A.; Dellen associated with filtering blebs. Arch Ophthalmol 1983,101(3),385-387","journal-title":"Arch Ophthalmol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/ceo.12431","volume":"43","author":"Goldberg I.","year":"2015","unstructured":"Goldberg I.; Graham S.L.; Crowston J.G.; d\u2019Mellow G.; Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease. Clin Exp Ophthalmol Australian and New Zealand Glaucoma Interest Group2015,43(3),214-220","journal-title":"Clin Exp Ophthalmol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/bjo.86.2.181","volume":"86","author":"Aragona P.","year":"2002","unstructured":"Aragona P.; Papa V.; Micali A.; Santocono M.; Milazzo G.; Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Br J Ophthalmol 2002,86(2),181-184","journal-title":"Br J Ophthalmol"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"263-73","DOI":"10.1016\/j.ejps.2008.04.006","volume":"34","author":"Pauloin T.","year":"2008","unstructured":"Pauloin T.; Dutot M.; Warnet J. M.; Rat P.; In vitro\nmodulation of preservative toxicity: high molecular weight\nhyaluronan decreases apoptosis and oxidative stress induced\nby benzalkonium chloride. European journal of pharmaceutical\nsciences: official journal of the European Federation\nfor Pharmaceutical Sciences 2008,34(4-5),263-73","journal-title":"European journal of pharmaceutical\nsciences: official journal of the European Federation\nfor Pharmaceutical Sciences"},{"key":"ref=81","first-page":"3409","volume":"43","author":"Debbasch C.","year":"2002","unstructured":"Debbasch C.; De La Salle S.B.; Brignole F.; Rat P.; Warnet J.M.; Baudouin C.; Cytoprotective effects of hyaluronic acid and Carbomer 934P in ocular surface epithelial cells. Invest Ophthalmol Vis Sci 2002,43(11),3409-3415","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1167\/iovs.12-11181","volume":"54","author":"Yu F.","year":"2013","unstructured":"Yu F.; Liu X.; Zhong Y.; Guo X.; Li M.; Mao Z.; Xiao H.; Yang S.; Sodium hyaluronate decreases ocular surface toxicity induced by benzalkonium chloride-preserved latanoprost: an in vivo study. Invest Ophthalmol Vis Sci 2013,54(5),3385-3393","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000357100","volume":"51","author":"Iester M.","year":"2014","unstructured":"Iester M.; Oddone F.; Fogagnolo P.; Frezzotti P.; Figus M.; Confocal Microscopy Study, G., Changes in the morphological and functional patterns of the ocular surface in patients treated with prostaglandin analogues after the use of TSP 0.5%(R) preservative-free eyedrops: a prospective, multicenter study. Ophthalmic Res 2014,51(3),146-152","journal-title":"Ophthalmic Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5301\/EJO.2010.5730","volume":"21","author":"Monaco G.","year":"2011","unstructured":"Monaco G.; Cacioppo V.; Consonni D.; Troiano P.; Effects of osmoprotection on symptoms, ocular surface damage, and tear film modifications caused by glaucoma therapy. Eur J Ophthalmol 2011,21(3),243-250","journal-title":"Eur J Ophthalmol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/IJG.0b013e318264cd68","volume":"23","author":"Batra R.","year":"2014","unstructured":"Batra R.; Tailor R.; Mohamed S.; Ocular surface disease exacerbated glaucoma: optimizing the ocular surface improves intraocular pressure control. J Glaucoma 2014,23(1),56-60","journal-title":"J Glaucoma"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1097\/ICO.0b013e318242fd60","volume":"31","author":"Sullivan B.D.","year":"2012","unstructured":"Sullivan B.D.; Crews L.A.; S\u00f6nmez B.; de la Paz M.F.; Comert E.; Charoenrook V.; de Araujo A.L.; Pepose J.S.; Berg M.S.; Kosheleff V.P.; Lemp M.A.; Clinical utility of objective tests for dry eye disease: variability over time and implications for clinical trials and disease management. Cornea 2012,31(9),1000-1008","journal-title":"Cornea"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jtos.2014.02.002","volume":"12","author":"Bron A.J.","year":"2014","unstructured":"Bron A.J.; Tomlinson A.; Foulks G.N.; Pepose J.S.; Baudouin C.; Geerling G.; Nichols K.K.; Lemp M.A.; Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf 2014,12(2)(Suppl.),S1-S31","journal-title":"Ocul Surf"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/aos.12012","volume":"92","author":"Sullivan B.D.","year":"2014","unstructured":"Sullivan B.D.; Crews L.A.; Messmer E.M.; Foulks G.N.; Nichols K.K.; Baenninger P.; Geerling G.; Figueiredo F.; Lemp M.A.; Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications. Acta Ophthalmol 2014,92(2),161-166","journal-title":"Acta Ophthalmol"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/173883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T02:17:13Z","timestamp":1571451433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/173883\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,20]]},"references-count":88,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,9,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867326666190725160621","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2017-11-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-01-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}